Cardio Diagnostics Financials
| CDIO Stock | USD 0.43 0.0005 0.12% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Debt Equity Ratio | 0.0659 | 0.0694 |
|
| |||||
| Current Ratio | 7.76 | 13.9162 |
|
|
Investors should never underestimate Cardio Diagnostics' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Cardio Diagnostics' cash flow, debt, and profitability to make informed and accurate decisions about investing in Cardio Diagnostics Holdings.
Net Income |
|
Cardio | Select Account or Indicator |
Understanding current and past Cardio Diagnostics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cardio Diagnostics' financial statements are interrelated, with each one affecting the others. For example, an increase in Cardio Diagnostics' assets may result in an increase in income on the income statement.
Cardio Diagnostics Stock Summary
Cardio Diagnostics competes with Day One, Mirum Pharmaceuticals, Rocket Pharmaceuticals, Avidity Biosciences, and Uniqure NV. Cardio Diagnostics Inc. develops and manufactures a genetic and epigenetic based test for prevention and detection of cardiovascular disease. Cardio Diagnostics Inc. was founded in 2017 and is based in Chicago, Illinois. Cardio Diagnostics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 14159C103 56168P104 |
| Location | Illinois; U.S.A |
| Business Address | 311 West Superior |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | cardiodiagnosticsinc.com |
| Phone | 302 281 2147 |
| Currency | USD - US Dollar |
Cardio Diagnostics Key Financial Ratios
| Return On Equity | -2.76 | ||||
| Operating Margin | (214.13) % | ||||
| Price To Sales | 632.82 X | ||||
| Revenue | 2.02 K | ||||
| Gross Profit | 35.69 K |
Cardio Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cardio Diagnostics's current stock value. Our valuation model uses many indicators to compare Cardio Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cardio Diagnostics competition to find correlations between indicators driving Cardio Diagnostics's intrinsic value. More Info.Cardio Diagnostics Holdings is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Cardio Diagnostics' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cardio Diagnostics' earnings, one of the primary drivers of an investment's value.Cardio Diagnostics Systematic Risk
Cardio Diagnostics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cardio Diagnostics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Cardio Diagnostics correlated with the market. If Beta is less than 0 Cardio Diagnostics generally moves in the opposite direction as compared to the market. If Cardio Diagnostics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cardio Diagnostics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cardio Diagnostics is generally in the same direction as the market. If Beta > 1 Cardio Diagnostics moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Cardio Diagnostics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cardio Diagnostics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Cardio Diagnostics growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Cardio Diagnostics March 26, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cardio Diagnostics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cardio Diagnostics Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cardio Diagnostics Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Cardio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cardio Diagnostics's daily price indicators and compare them against related drivers.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 48.64 | |||
| Value At Risk | (11.83) | |||
| Potential Upside | 13.33 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardio Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardio Diagnostics. If investors know Cardio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.31) | Revenue Per Share | Quarterly Revenue Growth (0.34) | Return On Assets | Return On Equity |
The market value of Cardio Diagnostics is measured differently than its book value, which is the value of Cardio that is recorded on the company's balance sheet. Investors also form their own opinion of Cardio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Cardio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardio Diagnostics' market value can be influenced by many factors that don't directly affect Cardio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardio Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.